Here's Vertex Willing Premium: Inside the Crinetics Deal
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
Analysis of entities with the lowest risk in crypto, plus how to interpret liquidity, use case maturity, and developer activity for safer bets.
28,397 articlesWhen a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...
Two popular clean-energy ETFs shape many investors' portfolios. This guide breaks down iShares Global Clean Energy an...
When rates stay elevated, not all financial stocks rise with them. This guide highlights the sectors and strategies m...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Rigetti Computing has dropped about 70% from its 52-week high. This article breaks down whether the dip offers real u...
AST SpaceMobile has surged, leaving investors asking whether spacemobile buy, sell, hold makes sense now. This articl...
A hypothetical spacex stock $2.5 trillion valuation invites big questions about revenue, profitability, and risk. Thi...
Friday Reads offers a disciplined way to close the week. This investing digest blends macro themes, private market pe...
A bold shift from a traditional hotel operator to AI-focused opportunities helped Ackman fuel outsized gains. Here’s ...
Dubai faces a destabilizing jolt as Iran launches strikes across the Gulf, prompting market turmoil, travel disruptio...